American Diversified Holdings unit GlucoGuard publishes investor deck for FDA research funding

• American Diversified Holdings published a GlucoGuard investor deck focused on funding research required for FDA approval.
• Deck posted at https://pr.report/qnho via the DECK tab on GlucoGuardSleep.com; password “Admin123”.
• Presentation outlines capital-raising talks with institutional investors; financing expected to accelerate development, with a spinoff included in negotiations.
• Deck highlights a revised Dexcom Level 2 app integration, including an emulator-ready app and a hypoglycemia prediction algorithm with 95% accuracy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Diversified Holdings Corporation published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202609230900ACCESSWRNAPR_____1225689) on September 23, 2026, and is solely responsible for the information contained therein.